Edition:
India

CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

6.80USD
25 Sep 2020
Change (% chg)

$0.25 (+3.74%)
Prev Close
$6.55
Open
$6.56
Day's High
$6.87
Day's Low
$6.50
Volume
242,301
Avg. Vol
212,894
52-wk High
$15.43
52-wk Low
$3.60

Select another date:

Mon, Jun 22 2020

BRIEF-Cytomx Therapeutics Announces Preclinical Data From Anti-Ctla-4 Probody Therapeutic Programs

* CYTOMX THERAPEUTICS ANNOUNCES PRECLINICAL DATA FROM ANTI-CTLA-4 PROBODY THERAPEUTIC PROGRAMS PRESENTED BY PARTNER BRISTOL MYERS SQUIBB AT AACR ANNUAL MEETING Source text for Eikon: Further company coverage:

BRIEF-Cytomx Therapeutics Announces Details Of Presentations At ASCO20

* CYTOMX THERAPEUTICS ANNOUNCES DETAILS OF PRESENTATIONS AT THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY ASCO20 VIRTUAL SCIENTIFIC PROGRAM Source text for Eikon: Further company coverage:

BRIEF-Cytomx Therapeutics Appoints Halley E. Gilbert To Board

* CYTOMX THERAPEUTICS APPOINTS HALLEY E. GILBERT TO BOARD OF DIRECTORS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-CytomX Therapeutics Says To Temporarily Pause New Patient Enrollment, New Site Activation In Proclaim-Cx-2009-001 Study

* CYTOMX THERAPEUTICS ANNOUNCES MILESTONE ACHIEVEMENT IN ABBVIE CD71 PARTNERSHIP AND PROVIDES UPDATE ON IMPACT OF COVID-19 ON CLINICAL STAGE PIPELINE

Select another date: